Oral Fluid Drug Testing: DOT's New Alternative to Urine Testing (2026)
DOT's 2023 final rule amending 49 CFR Part 40 added oral fluid as an employer option alongside urine drug testing. Here is what changed, how the collection process works, which labs qualify, and what it means for your motor carrier's drug testing program.
In This Guide
- What Changed: The 2023 Oral Fluid Final Rule
- Oral Fluid vs. Urine: Detection Windows and Practical Differences
- The Oral Fluid Collection Process Step-by-Step
- Laboratory Requirements: Only HHS-Certified Labs Qualify
- When to Use Oral Fluid vs. Urine (Carrier Decision Guide)
- Same Positive, Same Consequences: RTD and Clearinghouse
- Implementing Oral Fluid Testing in Your Program
- How FileFlo Tracks Drug Test Results Regardless of Specimen Type
What Changed: The 2023 Oral Fluid Final Rule
On May 2, 2023, the Department of Transportation published a final rule in the Federal Register (88 FR 27596) amending 49 CFR Part 40 to authorize oral fluid as an alternative specimen type for DOT-mandated drug testing. The rule became effective June 1, 2023.
Before this rule, DOT-regulated employers had one option for drug testing: urine. The 2023 rule added oral fluid as a second option, available alongside urine. It did not eliminate urine testing. It did not require employers to switch. It created a choice.
Important: Lab availability condition
The rule is in effect, but oral fluid testing cannot actually begin until HHS certifies at least two oral fluid testing laboratories. Check the HHS website for current certified laboratory status before planning any oral fluid collections.
The rule amends multiple sections of 49 CFR Part 40, including the subparts governing collection procedures, laboratory requirements, medical review officer responsibilities, and substance abuse professional processes. Every change was designed to parallel the existing urine framework — same substances, same cutoff logic, same consequences.
| Rule Element | Detail |
|---|---|
| Federal Register citation | 88 FR 27596 |
| Publication date | May 2, 2023 |
| Effective date | June 1, 2023 |
| Regulation amended | 49 CFR Part 40 |
| Specimen type added | Oral fluid (saliva) |
| Urine testing | Still valid — both methods available |
| Who chooses | Employer decides per collection occasion |
| HHS condition | Two certified oral fluid labs must be designated first |
| Testing panel | Same 5-panel as urine (THC, cocaine, opiates, amphetamines, PCP) |
| MRO process | Same as urine |
| Clearinghouse reporting | Same as urine |
Oral Fluid vs. Urine: Detection Windows and Practical Differences
The most significant practical difference between oral fluid and urine drug testing is the detection window. Understanding this difference is essential for choosing which method to use for which test type.
Oral Fluid (Saliva)
- Detection window: hours to 1–2 days for most substances
- Better for detecting recent or same-day use
- Observed collection — no privacy room needed
- Harder to adulterate or substitute
- Limited lab availability (HHS certification required)
- Ideal for: post-accident, reasonable suspicion
Urine
- Detection window: 1–3 days most substances, 30 days marijuana (chronic)
- Better for detecting use that occurred days earlier
- Requires private collection area
- Adulteration and substitution are documented risks
- Wide lab availability — well-established infrastructure
- Ideal for: pre-employment, random testing
The shorter detection window of oral fluid is not a weakness — it is a feature for specific use cases. Reasonable suspicion testing is one of the strongest examples. When a supervisor observes a driver showing signs of impairment right now, oral fluid is more likely to detect what caused that impairment than urine, which might show THC metabolites from three days ago that bear no relationship to the driver's current state.
Post-accident testing is similar. If a driver was involved in an accident two hours ago and shows behavioral signs consistent with impairment, oral fluid may provide more relevant toxicological information about the driver's condition at the time of the accident than urine would.
For pre-employment and random testing, where the goal is broader detection of habitual use rather than same-day impairment, urine's longer detection window may be preferable. Neither method is universally superior — the decision depends on what each test type is trying to find.
Are Your Fleet's Docs Current?
Free 3-minute check shows exactly which medical cards, CDLs, and DQF docs are expired or at risk. No signup. No email. Just answers.
The Oral Fluid Collection Process Step-by-Step
The oral fluid collection process is governed by subpart C of 49 CFR Part 40 as amended. The process is simpler in several respects than urine collection because it eliminates the need for a private collection area and makes observed collection the default rather than the exception.
Employer directs donor to collection site
The employer notifies the employee they must provide an oral fluid specimen. The collection must occur at an approved oral fluid collection site using an HHS-approved collection device. The site does not need a private restroom — oral fluid collection is inherently observed.
Collector verifies identity and explains process
The collector verifies the donor's identity using government-issued photo identification. The collector explains the collection procedure and answers questions. The donor must not have eaten, drunk, smoked, or chewed gum for at least 10 minutes before collection.
HHS-approved collection device used
The collector opens the HHS-approved oral fluid collection device in front of the donor. The device is placed in the donor's mouth by the donor, who swabs the inside of the cheeks and under the tongue for the period specified in the device instructions.
Two specimens collected (Specimen A and Specimen B)
Two separate oral fluid specimens must be collected in the same collection event. Specimen A is the primary specimen sent to the testing laboratory. Specimen B is the split specimen retained by the lab, available for re-analysis if the donor or MRO requests it. This mirrors the split specimen system used in urine collection.
Collector observes and seals specimens
The collector watches the donor provide both specimens. Once collected, the collector seals both specimen vials in front of the donor and affixes the tamper-evident tape. The collector and donor each initial the tape.
Oral fluid Custody and Control Form (CCF) completed
Oral fluid testing uses its own version of the federal Custody and Control Form — different from the urine CCF. Both the collector and donor must complete their respective sections. The donor signs to certify the specimen was provided as directed.
Specimens shipped to HHS-certified oral fluid lab
Both specimens are shipped to the HHS-certified oral fluid laboratory. Only laboratories with specific HHS certification for oral fluid testing are authorized to analyze DOT specimens — a standard HHS-certified urine lab is not automatically qualified for oral fluid.
MRO reviews and reports results
The Medical Review Officer reviews the laboratory results under the same process used for urine. Non-negative results require MRO interview with the donor before final verification. A verified positive result triggers the same obligations as a urine positive: Clearinghouse reporting, driver removal, SAP referral.
Insufficient specimen rule
If the donor cannot provide sufficient oral fluid on the first attempt, the collector must make a second attempt immediately. If both attempts fail, the situation is treated as a refusal to test — same as a shy bladder situation in urine testing. Document thoroughly and remove the driver from safety-sensitive functions immediately.
Laboratory Requirements: Only HHS-Certified Labs Qualify
This is the most critical practical constraint on oral fluid testing under the 2023 rule: not every HHS-certified urine testing laboratory is automatically authorized to test oral fluid specimens. Oral fluid specimens require separate HHS laboratory certification specifically for oral fluid.
The rule requires HHS to certify at least two oral fluid testing laboratories before DOT-regulated employers may begin using oral fluid testing. The two-lab requirement exists to protect the split specimen process — if a donor requests re-analysis of Specimen B, it must be sent to a different lab than the one that analyzed Specimen A.
Not Authorized for Oral Fluid
- Standard HHS-certified urine labs (without oral fluid certification)
- State-licensed clinical labs without HHS oral fluid certification
- Point-of-collection testing (POCT) devices — not for DOT use
- Employer-conducted instant test kits — prohibited for DOT
- Any lab not appearing on the HHS oral fluid certified list
Authorized for Oral Fluid
- HHS-certified laboratories with specific oral fluid certification
- Must appear on the HHS monthly certified lab list
- Must be able to analyze Specimen A and hold Specimen B
- Must follow HHS Mandatory Guidelines for Federal Workplace Drug Testing — Oral Fluid
- At least two such labs must be certified before any DOT use begins
Before scheduling any oral fluid collection for DOT-regulated employees, verify the current HHS certified laboratory list. The list is published monthly by the Substance Abuse and Mental Health Services Administration (SAMHSA) at samhsa.gov. If oral fluid labs are on the certified list, you may proceed. If not, continue using urine until certification is confirmed.
When to Use Oral Fluid vs. Urine: A Carrier Decision Guide
The 2023 rule gives employers flexibility to choose oral fluid or urine on a collection-by-collection basis. There is no requirement to standardize. This creates a useful opportunity to match the testing method to the circumstances of each test type.
| Test Type | Best Method | Reason |
|---|---|---|
| Pre-employment | Urine (recommended) | Longer detection window catches historical use; urine labs widely available |
| Random | Either (employer preference) | Random testing targets habitual use; urine's longer window may be preferred; oral fluid easier to collect on-site |
| Reasonable suspicion | Oral fluid (preferred) | Shorter window better reflects current impairment; observed collection simpler |
| Post-accident | Oral fluid (preferred) | Detects substances present at time of accident; no privacy room needed at accident scene |
| Return-to-duty | Either | RTD test confirms driver cleared SAP program; either method acceptable |
| Follow-up | Either | Follow-up tests are unannounced; oral fluid may be more practical for rapid collection |
Practical consideration for small carriers
Small carriers using a C/TPA for their random testing program should verify whether their C/TPA supports oral fluid collections before changing methods. C/TPAs must contract with oral fluid collection sites and HHS-certified oral fluid labs. If your C/TPA only supports urine, you cannot use oral fluid for random testing through that C/TPA until they expand their network.
Same Positive, Same Consequences: RTD and Clearinghouse
One of the most important things to understand about oral fluid testing is what does not change: a positive oral fluid test carries exactly the same consequences as a positive urine test. The specimen type is irrelevant to the consequences that follow a verified positive.
Immediate removal from safety-sensitive functions
A driver who tests positive on oral fluid must be immediately removed from operating a commercial motor vehicle. The removal is effective upon notification of the positive result to the employer. This is identical to urine.
Clearinghouse reporting within 2 business days
The MRO must report the verified positive to the FMCSA Drug and Alcohol Clearinghouse within 2 business days of verification. The Clearinghouse does not distinguish between specimen types — an oral fluid positive shows as a drug violation, period.
SAP evaluation and treatment required
The driver must be referred to a DOT-qualified Substance Abuse Professional and must complete any prescribed evaluation and treatment before they are eligible for return to duty. The SAP process is the same whether the original positive was oral fluid or urine.
Return-to-duty test required
After completing the SAP-prescribed treatment, the driver must pass a return-to-duty drug test (negative result) before resuming safety-sensitive functions. The employer may choose to use either oral fluid or urine for the return-to-duty test — it does not need to match the original positive specimen type.
Follow-up testing program (minimum 6 tests in 12 months)
Once the driver returns to duty, they must be enrolled in a follow-up testing program consisting of at least 6 unannounced tests in the first 12 months. This obligation exists regardless of whether the original positive was oral fluid or urine.
A refusal to provide an oral fluid specimen — including providing insufficient oral fluid on two consecutive attempts — is treated identically to a refusal to provide a urine specimen. The driver is removed from safety-sensitive functions and the refusal is reported to the Clearinghouse. There is no distinction between a refusal to test via oral fluid and a refusal to test via urine.
How audit-ready are you for DOT drug testing compliance?
Free 3-minute FMCSA audit readiness check. No signup, no credit card. See exactly which documents are expired or at risk.
Implementing Oral Fluid Testing in Your Program
Once HHS certifies oral fluid laboratories, the steps to implement oral fluid testing in a motor carrier's existing drug testing program are straightforward. Here is what needs to happen before your first oral fluid collection.
Step 1: Confirm HHS lab certification status
Before anything else: verify that at least two oral fluid laboratories appear on the current HHS certified lab list at samhsa.gov. If the certified list does not include oral fluid labs, you cannot proceed — continue with urine testing only.
Step 2: Verify your collection site and C/TPA support oral fluid
Contact your drug testing collection sites and your C/TPA (if you use one) to confirm they are equipped and trained for oral fluid collection. Collection sites need HHS-approved oral fluid collection devices. C/TPAs need contracts with HHS-certified oral fluid laboratories. Not all existing collection networks will be immediately ready.
Step 3: Update your drug and alcohol testing policy
If you decide to use oral fluid for some or all test types, update your written drug and alcohol testing program policy to reflect this. Your policy should specify which specimen type(s) you use for which test type(s). FMCSA compliance reviews may request your written policy. Keep a signed, dated copy in your compliance files.
Step 4: Train supervisors on oral fluid collection process
Supervisors who make reasonable suspicion testing decisions need to understand the oral fluid collection process, including what happens if the employee cannot provide a sufficient specimen. The two-attempt rule and the consequences of insufficient specimen must be part of supervisor training for any organization using oral fluid testing.
Step 5: Update record-keeping systems
Oral fluid drug tests use a different federal Custody and Control Form than urine tests. Your filing system needs to accommodate both forms. Retention requirements are identical to urine: positives retained 5 years, negatives 1 year, random testing records 2 years. All records belong in the driver's confidential drug and alcohol file, separate from the main DQF.
No retroactive changes needed
Switching to oral fluid for some test types does not require retroactive changes to existing driver files. Current employees' urine test records remain valid. You can begin using oral fluid for future collections without any action on historical records.
How FileFlo Tracks Drug Test Results Regardless of Specimen Type
FileFlo tracks all FMCSA-required drug and alcohol testing records in each driver's confidential file — whether the underlying test was urine or oral fluid. The specimen type does not change the record-keeping obligation or the retention timeline.
Pre-employment drug test results
FileFlo stores the MRO result, date, and specimen type. Retention tracked: 1 year for negatives, 5 years for positives.
Random testing documentation
Random selection records, notification timestamps, and test results tracked per driver. Retention: 2 years for negative results, 5 years for positives.
Clearinghouse query records
Pre-employment full query dates and annual limited query dates tracked per driver. Alerts sent when annual query window approaches expiration.
Return-to-duty and follow-up test tracking
RTD test results and follow-up testing schedules tracked in the driver's confidential file. FileFlo alerts on upcoming follow-up test windows.
Positive result and refusal documentation
Positive test records and refusal documentation retained in the confidential file for 5 years with automated retention deadline tracking.
C/TPA enrollment confirmation
Consortium/C/TPA enrollment records stored and verifiable during audits. Renewal reminders if consortium membership has an annual renewal date.
FileFlo's drug testing record module is specimen-type agnostic. Whether your carrier uses urine, oral fluid, or a mix of both depending on the test type, the same tracking system handles all records, all retention timelines, and all expiration alerts. When oral fluid labs are certified and your carrier begins implementing the new option, no changes to your FileFlo setup are required.
Drug testing records automatically tracked
FileFlo keeps every drug test record audit-ready
Pre-employment, random, post-accident, Clearinghouse queries — all in each driver's confidential file. $299/month. No credit card required.
Oral Fluid Drug Testing: FAQs for Motor Carriers
Common questions about DOT's 2023 oral fluid rule, collection procedures, detection windows, and implementation.
The rule permitting oral fluid testing under 49 CFR Part 40 was published on May 2, 2023, and took effect June 1, 2023. However, before any DOT-regulated employer can use oral fluid, HHS must certify at least two oral fluid testing laboratories. As of early 2026, check the HHS website for current certified laboratory status. Once two HHS-certified oral fluid labs are designated, employers may begin using oral fluid as an alternative to urine on a collection-by-collection basis. You do not need to switch your entire program — each collection occasion can be either urine or oral fluid.
Yes. DOT oral fluid testing uses the same five-panel test as urine: marijuana (THC), cocaine, opiates (codeine, morphine, heroin), amphetamines (including methamphetamine and MDMA), and phencyclidine (PCP). The substances are identical. However, the cutoff concentrations differ because oral fluid and urine matrices behave differently. DOT published specific oral fluid cutoff concentrations in the 2023 final rule. The MRO review process, reporting requirements, and Clearinghouse reporting obligations are identical for both specimen types.
Oral fluid typically detects recent drug use within a window of a few hours up to 1 to 2 days for most substances. Urine typically detects use from 1 to 3 days for most substances and up to 30 days for chronic marijuana use. Oral fluid is better at catching on-the-job or same-day impairment because the detection window is much shorter and more closely reflects current intoxication. Urine remains better for detecting use that occurred days earlier. This makes oral fluid particularly useful for reasonable suspicion and post-accident testing.
Not exactly. With urine, observed collections are an exception that requires supervisor authorization and specific justification (such as a prior positive or suspicion of specimen manipulation). With oral fluid, the collection is inherently observed by nature — the collector watches the donor place the collection device in their own mouth. There is no privacy concern because nothing is removed from the body in a private setting. This eliminates one of the most procedurally complex aspects of urine testing: the rules around direct observation.
If the collector is unable to collect a sufficient volume of oral fluid, the collector must make a second attempt immediately. If the second attempt also fails to produce a sufficient specimen, the situation is treated as a refusal to test — the same consequence as failing a urine drug test. This is similar to the shy bladder provision in urine testing. The collector documents the insufficient specimen situation and the employer must treat the driver as if they refused testing, which means removal from safety-sensitive functions and referral to a Substance Abuse Professional.
The employer — the motor carrier or regulated entity — decides whether to use oral fluid or urine for each collection occasion. This is a collection-by-collection decision. There is no requirement to commit to one method for your entire program. You could use urine for pre-employment testing and oral fluid for post-accident testing, for example. The only constraint is that you can only use the method you choose if HHS-certified oral fluid laboratories are available to analyze the specimen.
Yes, exactly the same as a urine positive. The Medical Review Officer who verifies the positive result is required to report it to the FMCSA Drug and Alcohol Clearinghouse within 2 business days. The driver must be removed from safety-sensitive functions immediately. The return-to-duty process, including SAP evaluation, treatment, and return-to-duty testing, is identical regardless of whether the original positive was oral fluid or urine. The Clearinghouse does not distinguish between specimen types.
The record-keeping requirements for oral fluid drug tests are identical to urine: positive results and refusals must be retained for 5 years, random testing selection records for 2 years, and negative results for 1 year. The MRO report, the chain of custody form (which is different from urine — oral fluid has its own federal custody and control form), and any Clearinghouse query results must all be retained in the driver's confidential drug and alcohol file, separate from the main DQF. FileFlo tracks retention deadlines for all drug testing records regardless of specimen type.
Related Articles
Continue learning about compliance and operational excellence
DOT Drug and Alcohol Testing Requirements: Complete 2026 Guide
Every DOT drug and alcohol testing requirement for motor carriers: the five test types, random testing rates, Clearinghouse obligations, and record-keeping timelines.
DOT Drug Testing Requirements for Small Fleets and Owner-Operators
C/TPA enrollment, random testing rates, Clearinghouse requirements, and all drug testing records small carriers must maintain.
FMCSA Violation Penalties 2026: Complete Fine Schedule for Motor Carriers
Every FMCSA penalty amount for 2026. Exact fines for DQF violations, expired medical cards, HOS, drug testing, and Clearinghouse — and how FMCSA calculates them.